MARKET

GILD

GILD

Gilead Sciences Inc
NASDAQ
130.04
-1.36
-1.04%
Pre Market: 129.90 -0.14 -0.11% 09:24 07/15 EDT
OPEN
129.70
PREV CLOSE
131.40
HIGH
131.21
LOW
129.42
VOLUME
398
TURNOVER
--
52 WEEK HIGH
155.38
52 WEEK LOW
105.01
MARKET CAP
161.45B
P/E (TTM)
17.69
1D
5D
1M
3M
1Y
5Y
1D
Should Gilead’s Revenue Beat but Softer EPS Outlook Require Action From Gilead Sciences (GILD) Investors?
Simply Wall St · 16h ago
BMO Capital Sticks to Their Buy Rating for Gilead Sciences (GILD)
TipRanks · 2d ago
Pliant Therapeutics appoints Flavia Borellini, Robert Iannone to board
PUBT · 2d ago
U.S. advises against Congo travel after second American aid worker contracts Ebola
Seeking Alpha · 2d ago
Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Quest Diagnostics (DGX) and Gilead Sciences (GILD)
TipRanks · 2d ago
Weekly Report: what happened at GILD last week (0706-0710)?
Weekly Report · 2d ago
Many Investors Are Still Treating Gilead Sciences Like a Has-Been HIV Stock. 4 Drug Launches This Year Could Prove Them Wrong.
The Motley Fool · 3d ago
Gilead Sciences Inc. Stock Slides 3.7%, Underperforms Peers
Dow Jones · 4d ago
More
About GILD
Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer, and inflammation. It is focused on discovering, developing, and delivering medicines to address unmet medical needs in virology, oncology, and other therapeutic areas. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP, Emtriva, Epclusa, Eviplera, Genvoya, Harvoni, Hepcludex, Hepsera, Jyseleca, Letairis, Livdelzi/Lyvdelzi, Odefsey, Sovaldi, Stribild, Sunlenca, Tecartus, Trodelvy, and others. It also sells and distributes authorized generic versions of Epclusa and Harvoni in the United States through its subsidiary, Asegua Therapeutics LLC. It has control on anitocabtagene autoleucel (anito cel), an investigational BCMA-directed CAR T cell therapy for multiple myeloma. The Company also owns an antibody-drug conjugates (ADCs) platform.

Webull offers Gilead Sciences, Inc stock information, including NASDAQ: GILD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GILD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GILD stock methods without spending real money on the virtual paper trading platform.